1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hormones
        1.2.3 Growth Factors
        1.2.4 Cytokines
        1.2.5 Plasma Protein Factor
        1.2.6 Recombinant Metabolic Enzymes
        1.2.7 Immune Checkpoint Regulators
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Recombinant Proteins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Biopharmaceutical Companies
        1.3.3 Academic and Research Institutes
        1.3.4 Contract Research Organizations
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Recombinant Proteins Market Perspective (2017-2028)
    2.2 Recombinant Proteins Growth Trends by Region
        2.2.1 Recombinant Proteins Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Recombinant Proteins Historic Market Size by Region (2017-2022)
        2.2.3 Recombinant Proteins Forecasted Market Size by Region (2023-2028)
    2.3 Recombinant Proteins Market Dynamics
        2.3.1 Recombinant Proteins Industry Trends
        2.3.2 Recombinant Proteins Market Drivers
        2.3.3 Recombinant Proteins Market Challenges
        2.3.4 Recombinant Proteins Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Recombinant Proteins Players by Revenue
        3.1.1 Global Top Recombinant Proteins Players by Revenue (2017-2022)
        3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2017-2022)
    3.2 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Recombinant Proteins Revenue
    3.4 Global Recombinant Proteins Market Concentration Ratio
        3.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2021
    3.5 Recombinant Proteins Key Players Head office and Area Served
    3.6 Key Players Recombinant Proteins Product Solution and Service
    3.7 Date of Enter into Recombinant Proteins Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Proteins Breakdown Data by Type
    4.1 Global Recombinant Proteins Historic Market Size by Type (2017-2022)
    4.2 Global Recombinant Proteins Forecasted Market Size by Type (2023-2028)
5 Recombinant Proteins Breakdown Data by Application
    5.1 Global Recombinant Proteins Historic Market Size by Application (2017-2022)
    5.2 Global Recombinant Proteins Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Recombinant Proteins Market Size (2017-2028)
    6.2 North America Recombinant Proteins Market Size by Type
        6.2.1 North America Recombinant Proteins Market Size by Type (2017-2022)
        6.2.2 North America Recombinant Proteins Market Size by Type (2023-2028)
        6.2.3 North America Recombinant Proteins Market Share by Type (2017-2028)
    6.3 North America Recombinant Proteins Market Size by Application
        6.3.1 North America Recombinant Proteins Market Size by Application (2017-2022)
        6.3.2 North America Recombinant Proteins Market Size by Application (2023-2028)
        6.3.3 North America Recombinant Proteins Market Share by Application (2017-2028)
    6.4 North America Recombinant Proteins Market Size by Country
        6.4.1 North America Recombinant Proteins Market Size by Country (2017-2022)
        6.4.2 North America Recombinant Proteins Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Recombinant Proteins Market Size (2017-2028)
    7.2 Europe Recombinant Proteins Market Size by Type
        7.2.1 Europe Recombinant Proteins Market Size by Type (2017-2022)
        7.2.2 Europe Recombinant Proteins Market Size by Type (2023-2028)
        7.2.3 Europe Recombinant Proteins Market Share by Type (2017-2028)
    7.3 Europe Recombinant Proteins Market Size by Application
        7.3.1 Europe Recombinant Proteins Market Size by Application (2017-2022)
        7.3.2 Europe Recombinant Proteins Market Size by Application (2023-2028)
        7.3.3 Europe Recombinant Proteins Market Share by Application (2017-2028)
    7.4 Europe Recombinant Proteins Market Size by Country
        7.4.1 Europe Recombinant Proteins Market Size by Country (2017-2022)
        7.4.2 Europe Recombinant Proteins Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Recombinant Proteins Market Size (2017-2028)
    8.2 Asia-Pacific Recombinant Proteins Market Size by Type
        8.2.1 Asia-Pacific Recombinant Proteins Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Recombinant Proteins Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Recombinant Proteins Market Share by Type (2017-2028)
    8.3 Asia-Pacific Recombinant Proteins Market Size by Application
        8.3.1 Asia-Pacific Recombinant Proteins Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Recombinant Proteins Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Recombinant Proteins Market Share by Application (2017-2028)
    8.4 Asia-Pacific Recombinant Proteins Market Size by Region
        8.4.1 Asia-Pacific Recombinant Proteins Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Recombinant Proteins Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Recombinant Proteins Market Size (2017-2028)
    9.2 Latin America Recombinant Proteins Market Size by Type
        9.2.1 Latin America Recombinant Proteins Market Size by Type (2017-2022)
        9.2.2 Latin America Recombinant Proteins Market Size by Type (2023-2028)
        9.2.3 Latin America Recombinant Proteins Market Share by Type (2017-2028)
    9.3 Latin America Recombinant Proteins Market Size by Application
        9.3.1 Latin America Recombinant Proteins Market Size by Application (2017-2022)
        9.3.2 Latin America Recombinant Proteins Market Size by Application (2023-2028)
        9.3.3 Latin America Recombinant Proteins Market Share by Application (2017-2028)
    9.4 Latin America Recombinant Proteins Market Size by Country
        9.4.1 Latin America Recombinant Proteins Market Size by Country (2017-2022)
        9.4.2 Latin America Recombinant Proteins Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Recombinant Proteins Market Size (2017-2028)
    10.2 Middle East & Africa Recombinant Proteins Market Size by Type
        10.2.1 Middle East & Africa Recombinant Proteins Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Recombinant Proteins Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Recombinant Proteins Market Share by Type (2017-2028)
    10.3 Middle East & Africa Recombinant Proteins Market Size by Application
        10.3.1 Middle East & Africa Recombinant Proteins Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Recombinant Proteins Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Recombinant Proteins Market Share by Application (2017-2028)
    10.4 Middle East & Africa Recombinant Proteins Market Size by Country
        10.4.1 Middle East & Africa Recombinant Proteins Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Recombinant Proteins Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abcam PLC
        11.1.1 Abcam PLC Company Details
        11.1.2 Abcam PLC Business Overview
        11.1.3 Abcam PLC Recombinant Proteins Introduction
        11.1.4 Abcam PLC Revenue in Recombinant Proteins Business (2017-2022)
        11.1.5 Abcam PLC Recent Developments
    11.2 R&D Systems
        11.2.1 R&D Systems Company Details
        11.2.2 R&D Systems Business Overview
        11.2.3 R&D Systems Recombinant Proteins Introduction
        11.2.4 R&D Systems Revenue in Recombinant Proteins Business (2017-2022)
        11.2.5 R&D Systems Recent Developments
    11.3 Miltenyi Biotec
        11.3.1 Miltenyi Biotec Company Details
        11.3.2 Miltenyi Biotec Business Overview
        11.3.3 Miltenyi Biotec Recombinant Proteins Introduction
        11.3.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2017-2022)
        11.3.5 Miltenyi Biotec Recent Developments
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Company Details
        11.4.2 Thermo Fisher Scientific Business Overview
        11.4.3 Thermo Fisher Scientific Recombinant Proteins Introduction
        11.4.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2017-2022)
        11.4.5 Thermo Fisher Scientific Recent Developments
    11.5 Sigma Aldrich Company
        11.5.1 Sigma Aldrich Company Company Details
        11.5.2 Sigma Aldrich Company Business Overview
        11.5.3 Sigma Aldrich Company Recombinant Proteins Introduction
        11.5.4 Sigma Aldrich Company Revenue in Recombinant Proteins Business (2017-2022)
        11.5.5 Sigma Aldrich Company Recent Developments
    11.6 GE Healthcare
        11.6.1 GE Healthcare Company Details
        11.6.2 GE Healthcare Business Overview
        11.6.3 GE Healthcare Recombinant Proteins Introduction
        11.6.4 GE Healthcare Revenue in Recombinant Proteins Business (2017-2022)
        11.6.5 GE Healthcare Recent Developments
    11.7 Lonza
        11.7.1 Lonza Company Details
        11.7.2 Lonza Business Overview
        11.7.3 Lonza Recombinant Proteins Introduction
        11.7.4 Lonza Revenue in Recombinant Proteins Business (2017-2022)
        11.7.5 Lonza Recent Developments
    11.8 Merck KGaA
        11.8.1 Merck KGaA Company Details
        11.8.2 Merck KGaA Business Overview
        11.8.3 Merck KGaA Recombinant Proteins Introduction
        11.8.4 Merck KGaA Revenue in Recombinant Proteins Business (2017-2022)
        11.8.5 Merck KGaA Recent Developments
    11.9 ProSpec Tany TechnoGene
        11.9.1 ProSpec Tany TechnoGene Company Details
        11.9.2 ProSpec Tany TechnoGene Business Overview
        11.9.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
        11.9.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2017-2022)
        11.9.5 ProSpec Tany TechnoGene Recent Developments
    11.10 Eurogentec (Kaneka Corporation)
        11.10.1 Eurogentec (Kaneka Corporation) Company Details
        11.10.2 Eurogentec (Kaneka Corporation) Business Overview
        11.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Introduction
        11.10.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2017-2022)
        11.10.5 Eurogentec (Kaneka Corporation) Recent Developments
    11.11 PeproTech
        11.11.1 PeproTech Company Details
        11.11.2 PeproTech Business Overview
        11.11.3 PeproTech Recombinant Proteins Introduction
        11.11.4 PeproTech Revenue in Recombinant Proteins Business (2017-2022)
        11.11.5 PeproTech Recent Developments
    11.12 BPS Bioscience
        11.12.1 BPS Bioscience Company Details
        11.12.2 BPS Bioscience Business Overview
        11.12.3 BPS Bioscience Recombinant Proteins Introduction
        11.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2017-2022)
        11.12.5 BPS Bioscience Recent Developments
    11.13 Reprocell
        11.13.1 Reprocell Company Details
        11.13.2 Reprocell Business Overview
        11.13.3 Reprocell Recombinant Proteins Introduction
        11.13.4 Reprocell Revenue in Recombinant Proteins Business (2017-2022)
        11.13.5 Reprocell Recent Developments
    11.14 GenScript Biotech Corporation
        11.14.1 GenScript Biotech Corporation Company Details
        11.14.2 GenScript Biotech Corporation Business Overview
        11.14.3 GenScript Biotech Corporation Recombinant Proteins Introduction
        11.14.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2017-2022)
        11.14.5 GenScript Biotech Corporation Recent Developments
    11.15 Abnova Corporation
        11.15.1 Abnova Corporation Company Details
        11.15.2 Abnova Corporation Business Overview
        11.15.3 Abnova Corporation Recombinant Proteins Introduction
        11.15.4 Abnova Corporation Revenue in Recombinant Proteins Business (2017-2022)
        11.15.5 Abnova Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Hormones
    Table 3. Key Players of Growth Factors
    Table 4. Key Players of Cytokines
    Table 5. Key Players of Plasma Protein Factor
    Table 6. Key Players of Recombinant Metabolic Enzymes
    Table 7. Key Players of Immune Checkpoint Regulators
    Table 8. Key Players of Others
    Table 9. Global Recombinant Proteins Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Recombinant Proteins Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Recombinant Proteins Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Recombinant Proteins Market Share by Region (2017-2022)
    Table 13. Global Recombinant Proteins Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Recombinant Proteins Market Share by Region (2023-2028)
    Table 15. Recombinant Proteins Market Trends
    Table 16. Recombinant Proteins Market Drivers
    Table 17. Recombinant Proteins Market Challenges
    Table 18. Recombinant Proteins Market Restraints
    Table 19. Global Recombinant Proteins Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Recombinant Proteins Revenue Share by Players (2017-2022)
    Table 21. Global Top Recombinant Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2021)
    Table 22. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Recombinant Proteins Product Solution and Service
    Table 26. Date of Enter into Recombinant Proteins Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Recombinant Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Recombinant Proteins Revenue Market Share by Type (2017-2022)
    Table 30. Global Recombinant Proteins Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Recombinant Proteins Revenue Market Share by Type (2023-2028)
    Table 32. Global Recombinant Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Recombinant Proteins Revenue Share by Application (2017-2022)
    Table 34. Global Recombinant Proteins Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Recombinant Proteins Revenue Share by Application (2023-2028)
    Table 36. North America Recombinant Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Recombinant Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Recombinant Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Recombinant Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Recombinant Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Recombinant Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Recombinant Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Recombinant Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Recombinant Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Recombinant Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Recombinant Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Recombinant Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Recombinant Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Recombinant Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Recombinant Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Recombinant Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Recombinant Proteins Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Recombinant Proteins Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Recombinant Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Recombinant Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Recombinant Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Recombinant Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Recombinant Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Recombinant Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Recombinant Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Recombinant Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Recombinant Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Recombinant Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Recombinant Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Recombinant Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Abcam PLC Company Details
    Table 67. Abcam PLC Business Overview
    Table 68. Abcam PLC Recombinant Proteins Product
    Table 69. Abcam PLC Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 70. Abcam PLC Recent Developments
    Table 71. R&D Systems Company Details
    Table 72. R&D Systems Business Overview
    Table 73. R&D Systems Recombinant Proteins Product
    Table 74. R&D Systems Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 75. R&D Systems Recent Developments
    Table 76. Miltenyi Biotec Company Details
    Table 77. Miltenyi Biotec Business Overview
    Table 78. Miltenyi Biotec Recombinant Proteins Product
    Table 79. Miltenyi Biotec Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 80. Miltenyi Biotec Recent Developments
    Table 81. Thermo Fisher Scientific Company Details
    Table 82. Thermo Fisher Scientific Business Overview
    Table 83. Thermo Fisher Scientific Recombinant Proteins Product
    Table 84. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 85. Thermo Fisher Scientific Recent Developments
    Table 86. Sigma Aldrich Company Company Details
    Table 87. Sigma Aldrich Company Business Overview
    Table 88. Sigma Aldrich Company Recombinant Proteins Product
    Table 89. Sigma Aldrich Company Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 90. Sigma Aldrich Company Recent Developments
    Table 91. GE Healthcare Company Details
    Table 92. GE Healthcare Business Overview
    Table 93. GE Healthcare Recombinant Proteins Product
    Table 94. GE Healthcare Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 95. GE Healthcare Recent Developments
    Table 96. Lonza Company Details
    Table 97. Lonza Business Overview
    Table 98. Lonza Recombinant Proteins Product
    Table 99. Lonza Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 100. Lonza Recent Developments
    Table 101. Merck KGaA Company Details
    Table 102. Merck KGaA Business Overview
    Table 103. Merck KGaA Recombinant Proteins Product
    Table 104. Merck KGaA Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 105. Merck KGaA Recent Developments
    Table 106. ProSpec Tany TechnoGene Company Details
    Table 107. ProSpec Tany TechnoGene Business Overview
    Table 108. ProSpec Tany TechnoGene Recombinant Proteins Product
    Table 109. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 110. ProSpec Tany TechnoGene Recent Developments
    Table 111. Eurogentec (Kaneka Corporation) Company Details
    Table 112. Eurogentec (Kaneka Corporation) Business Overview
    Table 113. Eurogentec (Kaneka Corporation) Recombinant Proteins Product
    Table 114. Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 115. Eurogentec (Kaneka Corporation) Recent Developments
    Table 116. PeproTech Company Details
    Table 117. PeproTech Business Overview
    Table 118. PeproTech Recombinant Proteins Product
    Table 119. PeproTech Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 120. PeproTech Recent Developments
    Table 121. BPS Bioscience Company Details
    Table 122. BPS Bioscience Business Overview
    Table 123. BPS Bioscience Recombinant Proteins Product
    Table 124. BPS Bioscience Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 125. BPS Bioscience Recent Developments
    Table 126. Reprocell Company Details
    Table 127. Reprocell Business Overview
    Table 128. Reprocell Recombinant Proteins Product
    Table 129. Reprocell Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 130. Reprocell Recent Developments
    Table 131. GenScript Biotech Corporation Company Details
    Table 132. GenScript Biotech Corporation Business Overview
    Table 133. GenScript Biotech Corporation Recombinant Proteins Product
    Table 134. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 135. GenScript Biotech Corporation Recent Developments
    Table 136. Abnova Corporation Company Details
    Table 137. Abnova Corporation Business Overview
    Table 138. Abnova Corporation Recombinant Proteins Product
    Table 139. Abnova Corporation Revenue in Recombinant Proteins Business (2017-2022) & (US$ Million)
    Table 140. Abnova Corporation Recent Developments
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Proteins Market Share by Type: 2021 VS 2028
    Figure 2. Hormones Features
    Figure 3. Growth Factors Features
    Figure 4. Cytokines Features
    Figure 5. Plasma Protein Factor Features
    Figure 6. Recombinant Metabolic Enzymes Features
    Figure 7. Immune Checkpoint Regulators Features
    Figure 8. Others Features
    Figure 9. Global Recombinant Proteins Market Share by Application: 2021 VS 2028
    Figure 10. Biopharmaceutical Companies Case Studies
    Figure 11. Academic and Research Institutes Case Studies
    Figure 12. Contract Research Organizations Case Studies
    Figure 13. Recombinant Proteins Report Years Considered
    Figure 14. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Recombinant Proteins Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Recombinant Proteins Market Share by Region: 2021 VS 2028
    Figure 17. Global Recombinant Proteins Market Share by Players in 2021
    Figure 18. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2021
    Figure 20. North America Recombinant Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Recombinant Proteins Market Size Market Share by Type (2017-2028)
    Figure 22. North America Recombinant Proteins Market Size Market Share by Application (2017-2028)
    Figure 23. North America Recombinant Proteins Market Size Share by Country (2017-2028)
    Figure 24. United States Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Recombinant Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Recombinant Proteins Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Recombinant Proteins Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Recombinant Proteins Market Size Share by Country (2017-2028)
    Figure 30. Germany Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Recombinant Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Recombinant Proteins Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Recombinant Proteins Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Recombinant Proteins Market Size Share by Region (2017-2028)
    Figure 40. China Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Latin America Recombinant Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Recombinant Proteins Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Recombinant Proteins Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Recombinant Proteins Market Size Share by Country (2017-2028)
    Figure 50. Mexico Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Recombinant Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Recombinant Proteins Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Recombinant Proteins Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Recombinant Proteins Market Size Share by Country (2017-2028)
    Figure 56. Turkey Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Recombinant Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 60. R&D Systems Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 61. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 63. Sigma Aldrich Company Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 64. GE Healthcare Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 65. Lonza Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 66. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 67. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 68. Eurogentec (Kaneka Corporation) Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 69. PeproTech Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 70. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 71. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 72. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 73. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed